Kirkland & Ellis advises Oakley Capital on the acquisition of a majority stake in vitroconnect.
Oakley Capital is investing alongside vitroconnect founder and CEO Dirk Pasternack and his management team who will continue to run the business. The transaction is subject to regulatory approval and is expected to complete around the end of H1 2024.
Based in Gütersloh, Germany, vitroconnect connects broadband providers with resellers through a proprietary, single interface software platform. The company works with most of Germany’s leading telco players, offering process automation, network operations, brokerage and white-label services through its Carrier Aggregation Platform (‘CAP’).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
